Related Experiment Video
Updated: Jul 4, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel node detection in patients with thyroid carcinoma: a meta-analysis.
P G H M Raijmakers1, M A Paul, P Lips
1Department of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam, The Netherlands. p.raijmakers@vumc.nl
World Journal of Surgery
|July 3, 2008
Summary
Technetium-99m colloid (99mTc) demonstrated a higher sentinel node (SN) detection rate (96%) compared to blue dye (83%) for assessing nodal status in thyroid carcinoma patients. This finding aids in improving diagnostic accuracy for thyroid cancer staging.
Area of Science:
- Oncology
- Nuclear Medicine
- Surgical Pathology
Background:
- Accurate nodal status assessment is crucial for thyroid carcinoma staging and treatment planning.
- Sentinel node (SN) biopsy is a minimally invasive technique for evaluating lymph node metastasis.
Purpose of the Study:
- To evaluate the diagnostic performance of SN detection in thyroid carcinoma.
- To compare the efficacy of blue dye versus Technetium-99m colloid (99mTc) for SN detection.
Main Methods:
- A systematic literature review of studies published up to December 2007 was conducted.
- MEDLINE database was searched for studies on SN procedures in thyroid disorders.
- Pooled detection rates and sensitivity with 95% confidence intervals were calculated for different SN detection techniques.
Main Results:
- Fourteen studies including 457 patients were analyzed.
- The blue dye technique showed a pooled SN detection rate of 83% (95% CI, 79-87%).
- The 99mTc-colloid technique achieved a significantly higher pooled SN detection rate of 96% (95% CI, 91-99%).
Conclusions:
- 99mTc-colloid is superior to blue dye for SN detection in patients with suspected thyroid carcinoma.
- The higher detection rate of 99mTc enhances the accuracy of nodal status assessment in thyroid cancer.
- SN biopsy using 99mTc offers improved diagnostic performance for staging thyroid carcinoma.
